taspine has been researched along with epidermal growth factor in 5 studies
Studies (taspine) | Trials (taspine) | Recent Studies (post-2010) (taspine) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
---|---|---|---|---|---|
51 | 0 | 26 | 24,155 | 217 | 4,699 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, F; Dong, Y; He, L | 1 |
Chen, Y; Dai, B; He, L; Wang, N; Zhang, J; Zhang, Y; Zheng, L | 1 |
Dai, BL; He, LC; Wang, N; Zhang, YM | 1 |
Chen, Y; He, L; Liu, C; Smith, WW; Wang, N; Zhan, Y; Zhang, J; Zhang, Y; Zheng, L | 1 |
He, HZ; Wang, N; Zhang, J; Zhang, YM; Zheng, L | 1 |
5 other study(ies) available for taspine and epidermal growth factor
Article | Year |
---|---|
[Enhancement of wound healing by taspine and its effect on fibroblast].
Topics: Alkaloids; Animals; Caulophyllum; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Epidermal Growth Factor; Fibroblasts; Male; Rats; Rats, Sprague-Dawley; Skin; Transforming Growth Factor beta; Transforming Growth Factor beta1; Wound Healing; Wounds and Injuries | 2005 |
Antitumor activity of taspine by modulating the EGFR signaling pathway of Erk1/2 and Akt in vitro and in vivo.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Berberidaceae; Cell Line; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Drugs, Chinese Herbal; Epidermal Growth Factor; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-akt; Random Allocation; Rhizome | 2011 |
[Effect of taspine derivatives on human liver cancer SMMC7721].
Topics: Alkaloids; Antineoplastic Agents; Carcinoma, Hepatocellular; Caulophyllum; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Epidermal Growth Factor; Flow Cytometry; Humans; Liver Neoplasms; Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A | 2011 |
A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
Topics: Acetanilides; Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Proliferation; Epidermal Growth Factor; ErbB Receptors; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2012 |
Tas13D inhibits growth of SMMC-7721 cell via suppression VEGF and EGF expression.
Topics: Alkaloids; Animals; Blotting, Western; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; ErbB Receptors; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2012 |